Kaya Limited (KAYA) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Kaya Limited stock ₹257, price ₹364, that is 29.4% below the price, quality 15 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Kaya Limited
KAYA · NSEOur calculation puts a fair price 29% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range ₹215.50 – ₹698.65 · fair‑value band ₹192.47 – ₹320.79 · the ₹363.50 price screens above the ₹256.63 fair value. As of Nov 10, 2026.
Every Wednesday you see whether Kaya is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Kaya Limited owns and operates skin and hair care clinics in India.
Show moreShow less
The company offers skin care products, such as facewash, cleansers, toners, moisturizers, creams, face serums, sunscreen lotions, kits and regimes, and wet wipes; hair care products that include shampoos, hair serums, hair lotions, hair oils, and hair masques; bath and body products; and nutraceutical products.
It also provides skin services comprising laser hair reduction, thermage, HIFU, dermal fillers, chemical peel, Q-switch laser, and skin brightening and lightening treatments, as well as ageing skin, acne scars, dull skin revitalisation, skin IV drips, eye circle, anti-wrinkle, and microneedling; hair services, such as hair loss concern management, PRP GF, hair thread, QR678, hair loss in men, hair loss and thinning for women, hair IV drips, and scalp care solutions; and body contouring services consisting of CM slim, Venus legacy, CoolSculpting, weight loss IV drips, and face fat reduction treatment.
The company sells its products through Kaya clinics, standalone stores, online, and third-party outlets. It has a partnership with Bien-Etre Ltd to develop skin personalization platform using DNA biomarkers and AI. Kaya Limited was founded in 2002 and is headquartered in Mumbai, India.
Stock analysis
Kaya Limited (KAYA) currently trades at ₹363.50, while our estimate is ₹256.63, 29% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₹192.47 (bear) to ₹320.79 (bull), the price of ₹363.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 15/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Kaya Limited reported revenue of ₹2.2B in FY2026 versus ₹3.2B in FY2022, a compound −9.0%/yr. Reported net income was −₹962M in FY2026.
Key figures
Market cap ₹5.2B (≈ $55.8M) Micro · P/S ratio 2.01 · EPS (TTM) ₹−64.86 · Net margin −42.3% · Return on equity −4,735% · Return on assets (EBIT) −10.4% (5-year average) · Operating margin −11.6% · Revenue (TTM) ₹2.3B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 14% below its 52-week high and 60% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −30% fair-value upside, at −29%, KAYA screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
KAYA screens overvalued: fair value 29% below the price. Compare with Colgate-Palmolive Company →
Compare Kaya Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 239 stocks
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Context: sector, industry, market
- Is the Consumer Discretionary sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Godrej Consumer Products Limited GODREJCP | ₹850.65 | ₹1,146 | +35% | vs KAYA |
| Puig Brands, S.A PUIG | €19.95 | €24.28 | +22% | vs KAYA |
| Henkel AG HEN | €78.20 | €82.55 | +6% | vs KAYA |
| Beiersdorf Aktiengesellschaft, BEI | €85.34 | €69.09 | −19% | vs KAYA |
| The Clorox Company CLX | $106.60 | $74.29 | −30% | vs KAYA |
| Church & Dwight Co CHD | $111.76 | $65.04 | −42% | vs KAYA |
| Colgate-Palmolive Company CL | $98.09 | $56.16 | −43% | vs KAYA |
| Marico Limited MARICO | ₹902.00 | ₹493.84 | −45% | vs KAYA |
| The Estée Lauder Companies Inc EL | $113.43 | $44.21 | −61% | vs KAYA |
| Hindustan Unilever Limited HINDUNILVR | ₹1,990 | ₹775.25 | −61% | vs KAYA |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Kaya Limited (KAYA) overvalued or undervalued?
What is the fair value of KAYA?
What is the quality score of KAYA?
What is the price target for Kaya Limited (KAYA)?
What is the Kaya Limited stock forecast for 2026?
What is the revenue of Kaya Limited (KAYA)?
What is the intrinsic value of Kaya Limited (KAYA)?
Is Kaya Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of KAYA?
How much is Kaya Limited worth?
What do the bullish and bearish scenarios say about KAYA?
How solid is the balance sheet of Kaya Limited (KAYA)?
How far is KAYA from its 52-week high?
Which stocks are comparable to Kaya Limited?
Is Kaya Limited stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Kaya Limited (KAYA)?
What should I pay attention to with Kaya Limited right now?
Key figures of Kaya Limited
How large is the market capitalisation of Kaya Limited (KAYA)?
What is the P/S ratio of Kaya Limited (KAYA)?
What are the earnings per share of Kaya Limited (KAYA)?
What is the net margin of Kaya Limited (KAYA)?
What is the return on equity of Kaya Limited (KAYA)?
What is the EBIT return on assets of Kaya Limited (KAYA)?
What is the operating margin of Kaya Limited (KAYA)?
How fast is revenue growing at Kaya Limited (KAYA)?
How much free cash flow does Kaya Limited (KAYA) generate?
How much net debt does Kaya Limited (KAYA) carry?
Watch Kaya Limited in the live analysis
One click puts Kaya Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.